Company: SXTPW
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001213900-25-043779
Chunk: 94

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 8
Chunk 94
---
 pre-funded warrants, which carry a nominal exercise price per share, in its computation of basic and diluted
net loss per share beginning on the date of issuance. The cumulative dividends accrued on the Series A Preferred Stock during the period
are reflected as an addition to net loss or a reduction of net income in determining basic and diluted net (loss) income attributable
to common stockholders.

As the Company reported a net loss for the three
months ended March 31, 2025, the calculation of diluted net loss per common share is the same as basic net loss per common share. For
the three months ended March 31, 2024, all securities that could potentially dilute basic net income per share in the future have been
excluded from the diluted calculation because the effect would be antidilutive.

As a result of the Reverse Stock Splits, which
were effective as of August 12, 2024 at a ratio of 1:12 and February 24, 2025 at a ratio of 1:5, all shares of outstanding common stock
and net (loss) income per common share calculations have been retroactively adjusted for all periods presented.

Related Parties

Parties are considered to be related to the Company
if the parties, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with
the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal
owners of the Company and its management and other parties with which the Company may deal with if one party controls or can significantly
influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully
pursuing its own separate interests.

Subsequent Events

The Company considers events or transactions that occur after the balance
sheet date, but prior to the issuance of the financial statements to provide additional evidence relative to certain estimates or to identify
matters that require additional disclosure. Subsequent events have been evaluated through May 15, 2025, which is the date the financial
statements were issued. See Note 12.

Recently Adopted and Issued Accounting Pronouncements

From time to time, the FASB issues Accounting
Standards Updates (“ASU”) to amend the authoritative literature in the ASC. The Company regularly evaluates new ASUs to determine
the impact that these pronouncements may have on the consolidated condensed financial statements. Other than the pronouncements listed